Roger Ngan

Yan Chai Hospitalprovides acute and extended care services. Its services include medical, social, education, charitable fund and columbarium. The company was founded in 1973 and is headquartered in Hong Kong.

The Toys Manufacturers' Association of Hong Kong represents toy manufacturers. The non-profit company is based in Hong Kong, Hong Kong.

Centum Charitas Foundation operates as a non-profit charitable organization. The private company is based in Hong Kong, Hong Kong.

May Cheong Group Ltd. is a toy manufacturer that aims to ensure that its products are manufactured in safe and humane environments. The private company was established in 1967 and has grown into an international toy manufacturer with two sizable factories located in China and sales offices in various locations. May Cheong Group is based in Hong Kong, HK, and has subsidiaries in Hong Kong and Italy. The Chinese company's BB Junior brand focuses on producing fun and interactive toys for children aged 9 months to 3 years, with a learning and cognitive skill component. The company's Maisto brand is well known for producing die-cast vehicle replicas, including officially licensed products and custom vehicles. The CEO of the company is Roger Ngan.

Novoheart Holdings, Inc. is a global stem cell biotechnology company. It engages in engineering prototypes of bio-artificial human heart tissues and chambers for drug discovery, cardio toxicity screening, diseases modeling and therapeutic applications. The firm products include Human Ventricular Cardiomyocytes (hvCM), Cardiac Anisotropic Sheet (hvCAS), Cardiac Anisotropic Patch (hvCAP), Cardiac Tissue Strip (hvCTS), and novoHeart. The company was founded by Michelle Khine, Kevin Costa and Ronald Li on April 28, 1964 and is headquartered in Vancouver, Canada.

Part of Novomed Ltd., Xellera Therapeutics Ltd is a Chinese company that operates commercial current Good Manufacturing Practice (cGMP) facilities for clinical-grade cell and gene therapy products. The company is based in Hong Kong, Hong Kong. Xellera's state-of-the-art cGMP labs follow international standards to ensure quality, safety, and efficacy of Advanced Therapy Medicinal Products (ATMP). Xellera provides a one-stop solution to cGMP manufacturing, spanning from early process development to manufacturing and analytical testing, product release as well as cryostorage. The company was founded in 2018 and the CEOs are Roger Ngan and Ronald Li. Xellera Therapeutics was acquired by Novoheart Holdings, Inc., part of Novomed Ltd. from November 23, 2020 on June 28, 2019 for $18.71 million.